AQR CAPITAL MANAGEMENT LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1167557
Greenwich, CT
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,605,305
+$353,787 QoQ
Shares Held
13,096
+10.3% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#156
of 342 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. PTGX ranks #132 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in PTGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,605,305 | 13,096 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,251,518 | 11,874 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $607,360 | 6,954 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $569,304 | 8,570 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $962,195 | 17,409 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,938,605 | 40,087 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $5,793,742 | 150,097 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,172,695 | 137,171 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $868,154 | 25,055 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,343,532 | 81,007 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $214,212 | 9,342 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $174,572 | 10,466 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $307,106 | 11,119 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $446,982 | 40,970 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $966,819 | 114,688 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $519,053 | 15,177 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $738,516 | 41,677 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,194,167 | 26,608 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $787,023 | 30,387 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $472,207 | 23,423 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $445,740 | 22,800 | Shares | Defined | 2020-11-16 | |
| 2020-03-31 | $80,109 | 11,347 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||